Clinical Trial Detail

NCT ID NCT02010645
Title Eltrombopag With Decitabine in Advanced Myelodysplastic Syndrome (MDS)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

bone marrow cancer

acute myeloid leukemia

Therapies

Decitabine + Eltrombopag

Age Groups: adult

No variant requirements are available.